KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amneal Pharmaceuticals (AMRX) Long-Term Debt Repayments (2017 - 2025)

Amneal Pharmaceuticals has reported Long-Term Debt Repayments over the past 8 years, most recently at -$5.6 billion for Q4 2025.

  • Quarterly results put Long-Term Debt Repayments at -$5.6 billion for Q4 2025, down 1642.75% from a year ago — trailing twelve months through Dec 2025 was -$2.8 billion (down 1357.36% YoY), and the annual figure for FY2025 was -$2.8 billion, down 1388.22%.
  • Long-Term Debt Repayments for Q4 2025 was -$5.6 billion at Amneal Pharmaceuticals, down from $2.6 billion in the prior quarter.
  • Over the last five years, Long-Term Debt Repayments for AMRX hit a ceiling of $2.6 billion in Q3 2025 and a floor of -$5.6 billion in Q4 2025.
  • Median Long-Term Debt Repayments over the past 5 years was $19.8 million (2023), compared with a mean of -$208.0 million.
  • Peak annual rise in Long-Term Debt Repayments hit 4586.29% in 2025, while the deepest fall reached 1642.75% in 2025.
  • Amneal Pharmaceuticals' Long-Term Debt Repayments stood at -$146.3 million in 2021, then plummeted by 56.42% to -$228.9 million in 2022, then crashed by 147.1% to -$565.6 million in 2023, then surged by 43.02% to -$322.3 million in 2024, then crashed by 1642.75% to -$5.6 billion in 2025.
  • The last three reported values for Long-Term Debt Repayments were -$5.6 billion (Q4 2025), $2.6 billion (Q3 2025), and $15.5 million (Q2 2025) per Business Quant data.